DRKS00017724已完成未知
Metastatic Melanoma Patients Under Immunotherapy: Monitoring of Therapeutic Success Using Liquid Biopsy and PET/CT in a Prospective Study - MM_PET/CT+LB
niversitäts-Hautklinik Tübingen0 个研究点目标入组 100 人开始时间: 2019年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •unresectable malignant melanoma stage IV
- •Age =18 years
- •Indicated dual immunotherapy with nivolumab and ipilimumab
- •PET/CT examinations for clinical indication before treatment initiation (baseline staging) and for therapy control (3-monthly)
- •at least one existing measurable lesion
排除标准
- •non-consenting patients
研究者
相似试验
招募中
2 期
Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids. The MEMBRAINS trialAdvanced melanoma2024-516585-11-00Region Hovedstaden50
进行中（未招募）
1 期
Treatment of skin cancer using a different approach than surgery using an electroporation device that makes the tumour absorb more drug while leaving the healthy tissue alone combined with an immune modulator that enhances the anti-tumour immune response.Advanced Melanoma CancerEUCTR2014-004420-22-IEniversity College Cork10
进行中（未招募）
1 期
Immunization of disease-free melanoma patients with different HLA-A2 peptides.We want to vaccine HLA-A2 patients who had a cutaneous melanoma at the following AJCC stage T3b-T4 N0 M0, Tx N1-3 M0, Tx Nx M0. Disease-free after surgery. With no previous immunizations with the same peptides is allowed if a CTL response was observed. And the patients must be met all the inclusion criteria.EUCTR2006-000228-14-BECliniques Universitaires Saint-Luc28
进行中（未招募）
不适用
Treatment of patients with metastatic melanoma with TadalafilPreviously treated metastatic melanoma in stage IV or III unresectableMedDRA version: 14.0Level: LLTClassification code 10027481Term: Metastatic melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003273-28-DERuprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D12
尚未招募
2 期
Treatment of patients with metastatic melanoma (AJCC stage IV or III unresectable) with the PDE-inhibitor Tadalafil:A Pilot Trial for Proof of Principle”DRKS00003495niversitätsklinikum Heidelberg12